BerGenBio ASA financials at a glance

+ Portfolio

The revenue of BerGenBio ASA is reported as 0.00035 billion Krone in the fiscal year 2023. The earnings were -0.13 Krone per share in 2023, which was 96.19 higher than 2022. And about -0.22544 billion Krone are reported as free cash flow in the financials of BerGenBio ASA 2023. No dividends were paid to the shareholders of the BerGenBio ASA stock OB:BGBIO in the financial year 2023.

kr0.35M

Revenue

kr-0.13

Earnings Per Share

100.00%

Gross Margin %

kr-,241.00M

Free Cash Flow

Revenue

0.35

Earnings Per Share

-0.13

Gross Margin %

100.00

Free Cash Flow

-,241.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017
Rev.	Revenue	N/A	kr0.35M	kr0.39M	kr0.80M	kr0.60M	kr8.90M	kr2.34M	kr0.00M
GM %	Gross Margin %	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	kr-0.29	kr-0.13	kr-3.41	kr-3.52	kr-3.43	kr-3.43	kr-3.60	kr-4.01
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	0	-0.00%	-0.00%
Sha.	Shares	N/AM	2,688.69M	88.66M	88.46M	87.26M	61.08M	54.71M	49.92M
OCF	Operating Cash Flow	N/A	kr-,225.10M	kr-,288.23M	kr-,308.44M	kr-,234.29M	kr-,184.15M	kr-,186.71M	kr-,168.11M
FCF	Free Cash Flow	N/A	kr-,241.00M	kr-,284.98M	kr-,305.31M	kr-,234.36M	kr0.00M	kr-,186.93M	kr-,168.45M
FCFS	Free Cash Flow Per Share	kr-0.35	kr-0.16	kr-3.25	kr-3.45	kr-3.13	kr-3.17	kr-3.51	kr-3.70

BerGenBio ASA financials at a glance

Financials

Discover